ALRN - Aileron Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-9.59M

Cash

16.72M

Avg Qtr Burn

-5.432M

Short % of Float

0.49%

Insider Ownership

9.02%

Institutional Own.

29.93%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ALRN-6924 Details Cancer, Small cell lung cancer, Solid tumor/s	Phase 1b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALRN-6924 Details Cancer, Breast cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ALRN-6924 Details Cancer, Non-small cell lung carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.